There are, nonetheless, challenges in store too, such as regulatory volatility, disruption in the supply chain, and increased competition, which could test its viability in the long term.

Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of Hims & Hers’ plan to combine all its dermatology services into one main ...

Shares of HIMS stock opened at $36.01 on Thursday. Hims & Hers Health has a 12-month low of $11.20 and a 12-month high of $72.98. The firm has a market capitalization of $8.00 billion, a price-to ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...

Read Our Latest Research Report on HIMS Hims & Hers Health Stock Up 4.7 % Shares of NYSE HIMS opened at $36.01 on Friday. Hims & Hers Health, Inc. has a 52 week low of $11.20 and a 52 week high of ...

Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against the other skincare stocks. According to NielsenIQ, the global beauty market is expected to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Do Gas Station "Bedroom" Pills Really Work? Except for the drink fridges and the candy aisle, a pharmacy and a gas station don’t have much in common. And as you might imagine, if you’re ...

An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted the ire of a pharmaceutical trade organisation that calls the campaign "nothing short ...